About this trial

This is a multicentric, retrospective, and prospective biomarker study.

Eligibility criteria

Qualifiers

None

Disqualifiers

Metastatic neoplasia

Treatment for other oncological pathologies

Congenital or acquired immunosuppression (HIV, organ transplant, pharmacological)

Trial design

Treatments tested in this trial

  • Multiparameter analysis of each sample

Treatment groups

No treatment groups listed

Locations

4
Istituto Tumori IRCCS Giovanni Paolo II di Bari70124, BariBari, Italy
Istituto Nazionale Tumori | "Fondazione Pascale"80131, NaplesNapoli, Italy
Università del Piemonte orientale28100, NovaraNovara, Italy
Azienda Ospedaliera Universitaria Pisana56126, PisaPisa, Italy

Sponsors and collaborators

National Cancer Institute, Naples

Lead sponsor